FR EA
1001-00003 · Client 1001 · Closing
closing-checklist.xlsx DOCUMENT M&A / Corporate
2 / 38 ← → ✕
Contract analysis Extract to table

[sheet: Closing Checklist]

Item No.CategoryDocument DescriptionResponsible PartyCounterparty / RecipientDue DateDelivery StatusDate DeliveredNotes
1I. Core Transaction DocumentsAsset Purchase Agreement — Execution Version (dated April 2, 2024), between Ardent Healthcare Acquisition Corp. and Cardinal Peak Industries, Inc.Calderwood & Harkness LLP / Barrow, Kensington & Pratt LLPAll PartiesJune 30, 2024DeliveredApril 2, 2024 (signed); June 30, 2024 (closing)Base Purchase Price: $620,000,000; DE governing law; executed April 2, 2024; closing effected June 30, 2024
2I. Core Transaction DocumentsDisclosure Schedules to Asset Purchase Agreement (Buyer's and Seller's schedules)Calderwood & Harkness LLP / Barrow, Kensington & Pratt LLPBuyer / SellerApril 2, 2024DeliveredApril 2, 2024Delivered concurrently with APA execution; covers excluded assets, excluded liabilities, material contracts, real property leases (37 locations), IP (PeakConnect, U.S. Reg. No. 5,412,887), Dawson litigation (Case No. 3:23-cv-01847), employee matters, healthcare permits, environmental, insurance
3I. Core Transaction DocumentsBill of Sale — CPI to Ardent Healthcare Acquisition Corp.Calderwood & Harkness LLPBuyerJune 30, 2024DeliveredJune 30, 2024Transfers all personal property assets included in acquired assets
4I. Core Transaction DocumentsAssignment and Assumption Agreement — CPI (assignor) to Ardent Healthcare Acquisition Corp. (assignee)Calderwood & Harkness LLPBuyer / SellerJune 30, 2024DeliveredJune 30, 2024Assigns assumed contracts and assumed liabilities (trade payables, assumed contract obligations, accrued PTO); expressly excludes Dawson litigation and pre-closing tax liabilities
5I. Core Transaction DocumentsIntellectual Property Assignment Agreement — PeakConnect platform and trademarks (U.S. Reg. No. 5,412,887), with 12-month license-back of Cardinal Peak Industries corporate nameCalderwood & Harkness LLPBuyer / SellerJune 30, 2024DeliveredJune 30, 2024Includes PeakConnect patient-engagement software; 12-month CPI name license-back
6I. Core Transaction DocumentsTransition Services Agreement — CPI to provide transitional back-office, IT, and administrative services for up to 9 months post-closingCalderwood & Harkness LLP / Barrow, Kensington & Pratt LLPBuyer / SellerJune 30, 2024DeliveredJune 30, 2024Service schedules, pricing, and termination provisions; HIPAA BAA required
7I. Core Transaction DocumentsEarnout Agreement — EBITDA earnout calculation, up to $45,000,000 aggregate; Tranche 1 up to $22,500,000 (Adj. EBITDA ≥ $85M, EP1 ending June 30, 2025); Tranche 2 up to $22,500,000 (Adj. EBITDA ≥ $95M, EP2 ending June 30, 2026); change of control accelerationCalderwood & Harkness LLPBuyer / Seller / Seller ShareholdersJune 30, 2024DeliveredJune 30, 2024Linear ramp: $4.50 per $1 EBITDA above $80M (Tr. 1) and $90M (Tr. 2) thresholds; change of control acceleration triggers 100% of remaining max earnout; dispute resolution provisions included
8II. Seller's Closing DeliverablesSeller's Closing Certificate — bring-down of representations and warranties, compliance with covenants, satisfaction of closing conditionsBarrow, Kensington & Pratt LLPBuyerJune 30, 2024DeliveredJune 30, 2024Signed by authorized officer of CPI
9II. Seller's Closing DeliverablesSecretary's Certificate of Seller — board resolutions authorizing the transaction, incumbency of officers, DE certificate of good standing, certificate of incorporation and bylawsBarrow, Kensington & Pratt LLPBuyerJune 30, 2024DeliveredJune 30, 2024Includes DE Secretary of State good standing certificate; CPI DE File No. 5487231
10II. Seller's Closing DeliverablesOfficer's Certificate re: No Material Adverse Effect — certification that no MAE has occurred from April 2, 2024 through June 30, 2024Barrow, Kensington & Pratt LLPBuyerJune 30, 2024DeliveredJune 30, 2024Covers interim period from APA signing to closing
11II. Seller's Closing DeliverablesFIRPTA Certificate — Seller's certification of non-foreign status under IRC § 1445Barrow, Kensington & Pratt LLPBuyerJune 30, 2024DeliveredJune 30, 2024CPI EIN: 82-3947561; address: 8400 Crescent Ridge Parkway, Suite 200, Nashville, TN 37215
12III. Buyer's Closing DeliverablesBuyer's Closing Certificate — bring-down of Buyer's reps and warranties, compliance with covenants, satisfaction of Buyer's closing conditionsCalderwood & Harkness LLPSellerJune 30, 2024DeliveredJune 30, 2024Signed by authorized officer of Ardent Healthcare Acquisition Corp.
13III. Buyer's Closing DeliverablesSecretary's Certificate of Buyer (Ardent Healthcare Acquisition Corp.) — board resolutions, incumbency, certificate of incorporation, DE good standingCalderwood & Harkness LLPSellerJune 30, 2024DeliveredJune 30, 2024Acquisition Sub DE File No. 7129384; formed January 22, 2024; registered agent: National Registered Services, Inc., 1209 Orange Street, Wilmington, DE 19801
14IV. Employment & Non-CompeteEmployment Agreement — Dr. Randall J. Whitfield (CEO), 3-year term commencing June 30, 2024Calderwood & Harkness LLPDr. Whitfield / BuyerJune 30, 2024DeliveredJune 30, 2024Governed by Tennessee law; 52% shareholder of CPI pre-closing
15IV. Employment & Non-CompeteEmployment Agreement — Elaine Whitfield-Torres (CCO), 3-year term commencing June 30, 2024Calderwood & Harkness LLPWhitfield-Torres / BuyerJune 30, 2024DeliveredJune 30, 2024Governed by Tennessee law; 18% shareholder of CPI pre-closing
16IV. Employment & Non-CompeteNon-Competition and Non-Solicitation Agreement — Dr. Randall J. Whitfield, 3-year restrictive covenant covering TN, GA, NC, SC, AL, VA, KYCalderwood & Harkness LLPDr. Whitfield / BuyerJune 30, 2024DeliveredJune 30, 2024Governed by Tennessee law; covers all 7 states of CPI operations
17IV. Employment & Non-CompeteNon-Competition and Non-Solicitation Agreement — Elaine Whitfield-Torres, 3-year restrictive covenant covering TN, GA, NC, SC, AL, VA, KYCalderwood & Harkness LLPWhitfield-Torres / BuyerJune 30, 2024DeliveredJune 30, 2024Governed by Tennessee law; covers all 7 states of CPI operations
18V. Financing DocumentsSenior Secured Credit Agreement — $400,000,000 facility ($310M Term Loan A at SOFR + 325 bps, 5-year; $90M Revolving Credit Facility at SOFR + 300 bps, 5-year, undrawn at closing) — Pinnacle National Bank, N.A. as Administrative Agent and Lead ArrangerPinnacle National Bank, N.A. / Calderwood & Harkness LLPBuyer / LendersJune 30, 2024DeliveredJune 30, 2024NY governing law; syndicate lenders: Horizon Commercial Lending Corp., Tidewater Savings Bank, N.A., Great Plains Capital Partners LLC; commitment letter dated April 2, 2024 (Project Cardinal)
19V. Financing DocumentsLegal Opinion of Calderwood & Harkness LLP — delivered to Pinnacle National Bank, N.A. as Administrative Agent re: authorization, enforceability, no conflicts, valid existence of Ardent Healthcare Acquisition Corp.Calderwood & Harkness LLP (Beatrice Holloway)Pinnacle National Bank, N.A.June 30, 2024DeliveredJune 30, 2024Covers APA and related agreements; opines on DE valid existence of Acquisition Sub
20V. Financing DocumentsFunds Flow Memorandum — detailed allocation of all sources and uses at closingCalderwood & Harkness LLPAll Parties / Pinnacle National BankJune 30, 2024DeliveredJune 30, 2024Sources: $310M TLA + $220M equity = $530M. Uses: $558M cash to Seller, $62M to escrow (Commonwealth Trust & Escrow Company), $87.4M payoff to Velthorn Merchant Bank, transaction fees, NWC adjustment (est. NWC $29.2M vs. target $28M)
21V. Financing DocumentsClosing Statement / Settlement Statement — reconciliation of $620M base purchase price with adjustmentsCalderwood & Harkness LLPBuyer / SellerJune 30, 2024DeliveredJune 30, 2024Net cash to Seller shareholders: Dr. Whitfield (52%), Whitfield-Torres (18%), Ridgeline Growth Equity Fund II LP (22%), other management (8%); escrow holdback of $62M; estimated NWC adjustment
22VI. Escrow DocumentsEscrow Agreement — among Ardent Healthcare Acquisition Corp., Cardinal Peak Industries, Inc., and Commonwealth Trust & Escrow CompanyCalderwood & Harkness LLPBuyer / Seller / Commonwealth Trust & Escrow CompanyJune 30, 2024DeliveredJune 30, 2024Escrow amount: $62,000,000 (10% × $620M); Tranche 1 release: $31M on June 30, 2025; Tranche 2 release: $31M on December 30, 2025; net of pending indemnification claims; DE governing law; contact: Martin Galbraith, VP, Corporate Trust Services
23VI. Escrow DocumentsWire transfer confirmation — $62,000,000 funded to Commonwealth Trust & Escrow Company escrow accountArdent Capital Partners III LP / Pinnacle National BankCommonwealth Trust & Escrow CompanyJune 30, 2024DeliveredJune 30, 2024Escrow funded from Buyer equity at closing
24VII. Payoff & Lien ReleasesPayoff Letter — Velthorn Merchant Bank, N.A., confirming outstanding principal of $87,400,000 under Credit Agreement dated March 15, 2018, as amendedBarrow, Kensington & Pratt LLP / Velthorn Merchant BankBuyer / SellerJune 26, 2024DeliveredJune 26, 2024Includes per diem interest, wire instructions, and agreement to file UCC termination statements upon receipt
25VII. Payoff & Lien ReleasesWire transfer of payoff amount to Velthorn Merchant Bank, N.A.Calderwood & Harkness LLP (via funds flow)Velthorn Merchant BankJune 30, 2024DeliveredJune 30, 2024Payoff of $87,400,000 funded at closing from purchase price proceeds
26VII. Payoff & Lien ReleasesUCC Termination Statements — filed with DE Secretary of State and TN Secretary of StateBarrow, Kensington & Pratt LLP / Velthorn Merchant BankPublic filingJune 28, 2024DeliveredJune 28, 2024Filed June 28, 2024; terminates Velthorn security interests in CPI assets
27VIII. Regulatory Filings & ConsentsState healthcare change-of-ownership notices — Tennessee, Georgia, North CarolinaHargrove, Sinclair & Demarest LLP (Angela Demarest) / Calderwood & Harkness LLPState regulatory agencies (TN, GA, NC)March 4, 2024DeliveredMarch 4, 2024Filed for states requiring pre-closing notification; no HSR filing required (below threshold for asset purchase of healthcare clinics, confirmed by counsel)
28VIII. Regulatory Filings & ConsentsState healthcare change-of-ownership notices — South Carolina, Alabama, Virginia, KentuckyHargrove, Sinclair & Demarest LLPState regulatory agencies (SC, AL, VA, KY)VariousDeliveredVarious dates pre-closingFilings made as required by each state's regulatory framework; see Healthcare Regulatory Compliance Memorandum dated March 20, 2024
29VIII. Regulatory Filings & ConsentsHSR Act FilingN/AN/AN/AN/ANot required; below threshold for asset purchase of healthcare clinics; confirmed by counsel
30VIII. Regulatory Filings & ConsentsMedicare/Medicaid change of ownership enrollment updates (CMS-855 forms)Hargrove, Sinclair & Demarest LLP / Buyer's operations teamCMS / State Medicaid agenciesPost-closingPending — Post-ClosingMedicare/Medicaid represent ~31% of CPI net revenue combined; enrollment transfer filings to be submitted promptly post-closing
31IX. Landlord ConsentsLandlord consents for assignment/change of control — 29 of 37 leased clinic locations require consentTiffany Rosenthal (Calderwood & Harkness LLP) / Barrow, Kensington & Pratt LLPIndividual landlordsJune 30, 2024Delivered (27 of 29); Pending (2)Various27 consents obtained pre-closing; 2 consents (Knoxville, TN clinic and Roanoke, VA clinic) outstanding at closing — Seller providing indemnification; 8 locations did not require consent; see Lease Consent Tracker for full detail; average remaining lease term 4.2 years across 37 locations
32X. InsuranceR&W Insurance Policy — Sentinel Specialty Insurance Company, Policy No. SSI-RWI-2024-05178Alder Risk Partners LLC (Philip Yuen, SVP) / Calderwood & Harkness LLPBuyerApril 10, 2024 (bound)DeliveredApril 10, 2024Coverage limit: $62,000,000 (10% of purchase price); retention: $6,200,000 (1% of purchase price, 50/50 split Buyer/Seller indemnification basket); underwriting counsel: Caldwell Strand LLP, Chicago, IL; excludes Dawson litigation and known tax matters; coordinates with APA indemnification cap of $124M (20%)
33X. InsuranceEvidence of Buyer's liability insurance / D&O coverage for Ardent Healthcare Acquisition Corp.Ardent Capital Management LLCSeller / LendersJune 30, 2024DeliveredJune 30, 2024Required under Credit Agreement and APA
34XI. Tax DocumentsDraft IRS Form 8594 — Asset Acquisition Statement under IRC § 1060Sylvia Hartwell (Calderwood & Harkness LLP, Tax) / Ashford & Creighton LLPBuyer / SellerJune 30, 2024 (draft); Final post-NWC true-upDelivered (draft)June 30, 2024Allocates $620M purchase price among 7 asset classes (I–VII); to be finalized after NWC true-up; see Section 338 / Asset Allocation Memorandum dated March 18, 2024
35XI. Tax DocumentsTax Structure Memorandum — IRC § 1060 allocation analysis, step-up in basis, state tax considerations across 7 states, earnout treatment as additional purchase priceSylvia Hartwell (Calderwood & Harkness LLP, Tax)Internal / Ardent Capital deal teamFebruary 8, 2024DeliveredFebruary 8, 2024Completed during diligence phase; supplemented by Ashford & Creighton LLP structuring analysis
36XII. Post-Closing ObligationsNet Working Capital final determination — NWC Target: $28,000,000; Estimated Closing NWC: $29,200,000; $500,000 de minimis collarAshford & Creighton LLP (Gregory Nolan) / Calderwood & Harkness LLPBuyer / SellerSeptember 28, 2024 (90 days post-closing)Pending — Post-ClosingDollar-for-dollar adjustment above/below NWC Target; no adjustment if difference ≤ $500K; Buyer to deliver proposed final NWC statement within 90 days of closing
37XII. Post-Closing ObligationsEarnout monitoring and payment — Tranche 1 (EP1 ends June 30, 2025; max $22.5M); Tranche 2 (EP2 ends June 30, 2026; max $22.5M)Ardent Healthcare Acquisition Corp. / Ardent Capital Management LLCSeller / Seller ShareholdersJune 30, 2025 (Tr. 1); June 30, 2026 (Tr. 2)Pending — Post-ClosingEarnout Tranche 1: linear ramp $80M–$85M EBITDA ($4.50/$1); Earnout Tranche 2: linear ramp $90M–$95M EBITDA ($4.50/$1); aggregate cap $45M; change of control acceleration provision
38XII. Post-Closing ObligationsEscrow releases — Tranche 1: $31M on June 30, 2025; Tranche 2: $31M on December 30, 2025 (net of pending indemnification claims)Commonwealth Trust & Escrow Company (Martin Galbraith)Buyer / SellerJune 30, 2025 / December 30, 2025Pending — Post-ClosingEscrow Agent: Commonwealth Trust & Escrow Company, 3801 Kennett Pike, Suite 250, Greenville, DE 19807
39XII. Post-Closing ObligationsIndemnification survival tracking — General reps: 18 months (expires December 30, 2025); Fundamental reps: 36 months (expires June 30, 2027); Tax reps: 60 days after statute of limitationsCalderwood & Harkness LLP (Beatrice Holloway / Derek Okonkwo)BuyerOngoingPending — Post-ClosingIndemnification cap: $124,000,000 (20% of $620M); basket: $3,100,000 (0.5%, first-dollar tipping); de minimis: $100,000 per claim; exclusive remedy (except fraud, willful breach, equitable relief)
40XII. Post-Closing ObligationsTSA wind-down — Transition Services Agreement expires 9 months post-closing (March 30, 2025)Ardent Healthcare Acquisition Corp. operations teamCPI (Seller)March 30, 2025Pending — Post-ClosingCPI providing back-office, IT, and admin services; HIPAA BAA in place
41XII. Post-Closing ObligationsForm 8594 finalization and filing with IRSSylvia Hartwell (Calderwood & Harkness LLP) / Ashford & Creighton LLPIRSWith applicable tax returnsPending — Post-ClosingTo be finalized after NWC true-up; Buyer EIN: 93-2184720; Seller EIN: 82-3947561
42XII. Post-Closing ObligationsDocument retention — transaction documents to be maintained per Calderwood & Harkness LLP retention policy and client instructionsCalderwood & Harkness LLPBuyerOngoingPending — Post-ClosingSee Post-Closing Letter to Client dated July 3, 2024
SUMMARYTotal Items: 42Delivered: 34Pending (Post-Closing): 7N/A: 1

[sheet: Summary]

FieldValue
MatterAcquisition of Cardinal Peak Industries, Inc. by Ardent Healthcare Acquisition Corp.
C&H Matter No.2024-M&A-0142
ClientArdent Capital Partners III LP (590 Madison Avenue, 34th Floor, New York, NY 10022)
Client ContactMarcus Ainsworth, Managing Partner; Priya Mehta-Sullivan, Partner; Connor Briggs, Vice President
SellerCardinal Peak Industries, Inc. (8400 Crescent Ridge Parkway, Suite 200, Nashville, TN 37215)
Seller's CounselBarrow, Kensington & Pratt LLP (Catherine Barrow / Samuel Otieno)
Buyer's Counsel (Responsible Partner)Beatrice Holloway, Calderwood & Harkness LLP
Billing PartnerJames Prentice, Calderwood & Harkness LLP
Lead AssociateDerek Okonkwo, Calderwood & Harkness LLP
Working AssociateTiffany Rosenthal, Calderwood & Harkness LLP
Tax PartnerSylvia Hartwell, Calderwood & Harkness LLP
Healthcare Regulatory CounselAngela Demarest, Hargrove, Sinclair & Demarest LLP
Base Purchase Price$620,000,000
Maximum Earnout$45,000,000
Transaction StructureAsset Purchase
APA Signing DateApril 2, 2024
Target Closing DateJune 20, 2024
Actual Closing DateJune 30, 2024
Governing Law (APA)Delaware
Governing Law (Credit Agreement)New York
Governing Law (Employment/Non-Competes)Tennessee
Total Checklist Items42
Items Delivered34
Items Pending (Post-Closing)7
Items N/A1 (HSR Filing)
Prepared ByDerek Okonkwo / Tiffany Rosenthal, Calderwood & Harkness LLP
Last UpdatedJuly 1, 2024

[sheet: Key Parties & Contacts]

RoleEntityContact PersonTitleAddress
BuyerArdent Capital Partners III LPMarcus Ainsworth / Priya Mehta-Sullivan / Connor BriggsManaging Partner / Partner / Vice President590 Madison Avenue, 34th Floor, New York, NY 10022
Acquisition Sub (Purchaser)Ardent Healthcare Acquisition Corp.Connor Briggs (day-to-day deal lead)Vice Presidentc/o National Registered Services, Inc., 1209 Orange Street, Wilmington, DE 19801
SellerCardinal Peak Industries, Inc.Dr. Randall J. Whitfield / Elaine Whitfield-TorresChairman & CEO / Co-Founder & CCO8400 Crescent Ridge Parkway, Suite 200, Nashville, TN 37215
Minority Shareholder (Seller side)Ridgeline Growth Equity Fund II LP (GP: Ridgeline Growth Equity Advisors LLC)3344 Peachtree Road NE, Suite 1500, Atlanta, GA 30326
Buyer's CounselCalderwood & Harkness LLPBeatrice Holloway (Responsible Partner) / Derek Okonkwo (Lead Associate) / Tiffany Rosenthal (Associate)Partner / Associate / AssociateOne World Financial Center, 200 Liberty Street, 40th Floor, New York, NY 10281
Seller's CounselBarrow, Kensington & Pratt LLPCatherine "Kit" Barrow / Samuel OtienoCo-Managing Partner / Lead Associate1201 Demonbreun Street, Suite 1800, Nashville, TN 37203
Administrative Agent / Lead ArrangerPinnacle National Bank, N.A.Laura FitzgibbonsManaging Director, Healthcare Lending300 Vesey Street, New York, NY 10281
Syndicate LenderHorizon Commercial Lending Corp.New York, NY
Syndicate LenderTidewater Savings Bank, N.A.Virginia
Syndicate LenderGreat Plains Capital Partners LLCKansas
Payoff Bank (Seller's Existing Lender)Velthorn Merchant Bank, N.A.Massachusetts
Escrow AgentCommonwealth Trust & Escrow CompanyMartin GalbraithVice President, Corporate Trust Services3801 Kennett Pike, Suite 250, Greenville, DE 19807
Buyer's Financial AdvisorGraystone Partners LLCNathaniel "Nate" PrescottManaging Director787 Seventh Avenue, 22nd Floor, New York, NY 10019
Seller's Financial AdvisorMeridian Oak Advisory GroupDiana Vasquez-ReidSenior Managing Director4000 West End Avenue, Suite 600, Nashville, TN 37205
Buyer's Accounting AdvisorAshford & Creighton LLPGregory Nolan, CPAPartner, Transaction Advisory ServicesOne Liberty Plaza, 45th Floor, New York, NY 10006
Seller's AuditorLinden Hayes & Co., P.C.Roberta Chen, CPAAudit Partner500 Church Street, Suite 1400, Nashville, TN 37219
R&W Insurance CarrierSentinel Specialty Insurance CompanyPolicy No. SSI-RWI-2024-05178Illinois
R&W Insurance BrokerAlder Risk Partners LLCPhilip YuenSenior Vice President452 Fifth Avenue, 12th Floor, New York, NY 10018
R&W Underwriting CounselCaldwell Strand LLP155 North Wacker Drive, Suite 3200, Chicago, IL 60606
Healthcare Regulatory CounselHargrove, Sinclair & Demarest LLPAngela DemarestPartner, Healthcare Regulatory1717 K Street NW, Suite 900, Washington, DC 20006
Title CompanyCornerstone Land Title Company222 Second Avenue South, Nashville, TN 37201
Environmental ConsultantWhitmore Environmental Sciences Inc.2900 Woodland Park Drive, Atlanta, GA 30339
Registered Agent (Acquisition Sub)National Registered Services, Inc.1209 Orange Street, Wilmington, DE 19801

[sheet: Key Dates Timeline]

DateEventStatusNotes
January 15, 2024Calderwood & Harkness engagement letter signed; matter opened (Matter No. 2024-M&A-0142)CompletedBeatrice Holloway (Responsible Partner), James Prentice (Billing Partner)
January 22, 2024Ardent Healthcare Acquisition Corp. formed in DelawareCompletedDE File No. 7129384; EIN 93-2184720
January 29, 2024Letter of Intent executedCompleted
February 5, 2024Due diligence commencedCompleted
February 8, 2024Tax Structure Memorandum circulated (Sylvia Hartwell)CompletedIRC § 1060 analysis, asset purchase structure
February 12, 2024First draft APA circulated by Calderwood & Harkness to Barrow, Kensington & Pratt LLPCompleted
March 4, 2024State healthcare change-of-ownership notices filed (TN, GA, NC)CompletedFiled by Hargrove, Sinclair & Demarest LLP
March 12, 2024Litigation and Regulatory Review Memorandum (Derek Okonkwo)CompletedDawson v. CPI, Case No. 3:23-cv-01847 (M.D. Tenn.); est. exposure $2.8M–$5.1M
March 18, 2024Section 338 / Asset Allocation Memorandum (Sylvia Hartwell)CompletedProposed allocation of $620M across asset classes I–VII
March 20, 2024Healthcare Regulatory Compliance Memorandum (joint C&H / HSD)CompletedAnti-kickback / Stark Law analysis; Medicare/Medicaid enrollment
March 25, 2024Due Diligence Summary Memorandum circulatedCompletedComprehensive findings across all legal workstreams
April 2, 2024APA signed; Financing commitment letter executed (Project Cardinal)CompletedBase purchase price $620M; earnout up to $45M; 20% indemnification cap ($124M); 18-month survival; 10% escrow ($62M)
April 8, 2024R&W Insurance Coverage Memorandum circulatedCompletedAnalysis of Sentinel policy SSI-RWI-2024-05178
April 10, 2024R&W insurance policy boundCompletedSentinel Specialty Insurance Company; $62M coverage; $6.2M retention
June 14, 2024Pre-Closing Deficiency Letter sent to Seller's CounselCompletedOutstanding items: certain landlord consents, Velthorn payoff letter, updated good standing, officer's MAE certificate
June 20, 2024Target closing date per APAPassedClosing delayed to June 30, 2024
June 26, 2024Velthorn Merchant Bank payoff letter datedCompletedOutstanding principal: $87,400,000
June 28, 2024UCC termination statements filed (DE and TN)CompletedTerminates Velthorn security interests
June 30, 2024ACTUAL CLOSING DATECompletedAll closing deliverables exchanged; funds wired
September 28, 2024NWC final determination deadline (90 days post-closing)UpcomingNWC Target: $28M; Est. Closing NWC: $29.2M; $500K de minimis collar
March 30, 2025TSA expiration (9 months post-closing)Upcoming
June 30, 2025Escrow Tranche 1 release ($31M); Earnout Period 1 endsUpcomingEarnout Tranche 1: up to $22.5M if Adj. EBITDA ≥ $85M
December 30, 2025Escrow Tranche 2 release ($31M); General R&W survival expirationUpcoming18 months post-closing
June 30, 2026Earnout Period 2 endsUpcomingEarnout Tranche 2: up to $22.5M if Adj. EBITDA ≥ $95M

June 30, 2027